Condition

Influenza

ClinicalTrials.gov condition label

Clinical trials37

Recruiting2

Common interventions25

Lead sponsors shown15

Clinical trials

37 shown

Surveillance, Assessment and Detection of Influenza Associated Respiratory Infections in HIV Positive and Negative Individual in Lusaka, Zambia.NCT07030075 · 2025-05-20

COVID-19 Booster and IIV Schedule in Immunocompromised HostsNCT06599658 · 2024-11-20

Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted EngagementNCT06571747 · 2024-09-05

ACTIVE_NOT_RECRUITING

Building Engagement Using Financial Incentives Trial - Colorectal Cancer ScreeningNCT06124131 · 2023-11-11

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.NCT06259487 · 2023-09-15

One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.NCT05069714 · 2021-10-01

Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)NCT06252051 · 2021-01-05

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNCT04239521 · 2020-10-01

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated InfluenzaNCT06286488 · 2020-09-15

Audio Data Collection for Identification and Classification of CoughingNCT04326309 · 2020-03-25

Safety of LAIV4 in Children With AsthmaNCT03600428 · 2018-10-15

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 YearsNCT03694392 · 2018-09-16

2-week dc of MTX and Influenza Vaccination in RANCT02897011 · 2016-09-01

Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)NCT02762851 · 2016-06-01

Lower Respiratory Tract Infections Managed in Primary Care in FranceNCT07416266 · 2015-01-01

Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in AdultsNCT01811823 · 2014-03-31

Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected WomenNCT01816464 · 2013-09-01

Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in UgandaNCT01916759 · 2013-06-01

Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected WomenNCT01812980 · 2013-05-01

Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant WomenNCT01527825 · 2012-09-01

Immunogenicity of Influenza Vaccines in HIV-infected Persons in ThailandNCT01538940 · 2011-11-01

TIV and High Dose TIV in Subjects With Rheumatoid ArthritisNCT01436370 · 2011-10-01

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis PatientsNCT01512056 · 2011-10-01

Influenza Vaccine Trial in HIV Uninfected Pregnant WomenNCT01306669 · 2011-03-03

Influenza Vaccination of HIV Infected Pregnant Women: Safety and ImmunogenicityNCT01306682 · 2011-03-01

Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)NCT01146119 · 2010-07-01

Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected PatientsNCT01039220 · 2009-12-01

H1N1 Vaccine at Two Dose Levels in HIV Positive AdultsNCT00992433 · 2009-11-01

Vaccination Against Influenza H1N1 in Rheumatic DiseasesNCT01006681 · 2009-11-01

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected PersonsNCT00996970 · 2009-10-01

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised SubjectsNCT00979251 · 2009-09-01

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic UseNCT01050465 · 2009-05-01

Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, JerusalemNCT00758212 · 2008-11-01

Influenza Vaccine in HIVNCT00764998 · 2008-10-01

Efficacy of Influenza Vaccine in HIV Infected AdultsNCT00757900 · 2008-04-01

T-cell Response-Flu Risk in Older AdultsNCT00138398 · 2005-10-25

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and AdolescentsNCT00091702

Common interventions

Normal salineBIOLOGICAL3 Trivalent inactivated influenza vaccineBIOLOGICAL3 Trivalent Influenza VaccineBIOLOGICAL3 AdimFlu-SDRUG1 Adjuvanted PBSBIOLOGICAL1 ADS-8902DRUG1 Cardiovascular-Focused Nudge CommunicationBEHAVIORAL1 Cold-adapted live attenuated influenza vaccine (FluMist)BIOLOGICAL1 Commercial TriValent Split Influenza VirusBIOLOGICAL1 Coordinated VaccinationBIOLOGICAL1 COVID-19 Vaccines at a 3-month intervalBIOLOGICAL1 COVID-19 Vaccines at a 6-month intervalBIOLOGICAL1 Exposure of interest (studies 2 & 3).OTHER1 Financial incentive for colorectal cancer screeningBEHAVIORAL1 Financial incentive for COVID-19 shotBEHAVIORAL1 Financial incentive for flu shotBEHAVIORAL1 Flublok QuadrivalentBIOLOGICAL1 FluviralBIOLOGICAL1 Focetria (Monovalent MF59-Adjuvanted vaccine)BIOLOGICAL1 Following recommendationsBEHAVIORAL1 health information prescriptionOTHER1 Inactivated Influenza H1N1 vaccineBIOLOGICAL1 Inactivated influenza vaccine (IAIV)BIOLOGICAL1 Inactivated Influenza Vaccine (IIV)BIOLOGICAL1 Inactivated influenza vaccine (IIV) at baselineBIOLOGICAL1

Leading sponsors

University of Witwatersrand, South Africa7 National Institute of Allergy and Infectious Diseases (NIAID)4 Kaiser Permanente2 Seoul National University Hospital2 Adamas Pharmaceuticals, Inc.1 BiondVax Pharmaceuticals ltd.1 Centers for Disease Control and Prevention1 Centre for Infectious Disease Research in Zambia1 Emory University1 French National Agency for Research on AIDS and Viral Hepatitis1 Hadassah Medical Organization1 HealthMode Inc.1 Henry M. Jackson Foundation for the Advancement of Military Medicine1 Hôpital Raymond Poincaré1 McGill University Health Centre/Research Institute of the McGill University Health Centre1

Trial status mix

COMPLETED27

UNKNOWN7

RECRUITING2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE410

NA9

PHASE28

PHASE35

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.